Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : GOPwinger Lies/Distortions/Omissions/Perversions of Truth -- Ignore unavailable to you. Want to Upgrade?

To: SeachRE who wrote (158898)	4/28/2009 11:59:51 PM
From: Stormin Norman	Read Replies (1) \| Respond to of 173976

Those DNDN shorts will be feeling the pain. And you said it yourself here....... <<<Individualized therapy sounds good but is also impractical...unless it's a major breakthrough.>>> DNDN's Provenge is not just an individual therapy breakthrough, Provenge is a historical breakthrough. History has been made by Dendreon, just to bad that America is done for, cause DNDN has nearly whipped cancer. With continued progress, chemotherapy would have been a thing of the past. Unfortunately, health care will be a thing of the past.